nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—ABCB1—colon cancer	0.397	1	CbGaD
Selegiline—CYP2A6—Fluorouracil—colon cancer	0.0831	0.213	CbGbCtD
Selegiline—CYP2B6—Irinotecan—colon cancer	0.0564	0.144	CbGbCtD
Selegiline—CYP2C9—Capecitabine—colon cancer	0.0482	0.123	CbGbCtD
Selegiline—CYP2C8—Fluorouracil—colon cancer	0.041	0.105	CbGbCtD
Selegiline—CYP1A2—Fluorouracil—colon cancer	0.0317	0.0812	CbGbCtD
Selegiline—ABCB1—Irinotecan—colon cancer	0.0289	0.0739	CbGbCtD
Selegiline—CYP2C9—Fluorouracil—colon cancer	0.0286	0.0731	CbGbCtD
Selegiline—ABCB1—Vincristine—colon cancer	0.0253	0.0646	CbGbCtD
Selegiline—CYP3A4—Irinotecan—colon cancer	0.0173	0.0443	CbGbCtD
Selegiline—ABCB1—Methotrexate—colon cancer	0.0153	0.0391	CbGbCtD
Selegiline—CYP3A4—Vincristine—colon cancer	0.0151	0.0387	CbGbCtD
Selegiline—MAOB—embryo—colon cancer	0.000605	0.0468	CbGeAlD
Selegiline—MAOA—embryo—colon cancer	0.000517	0.04	CbGeAlD
Selegiline—MAOB—renal system—colon cancer	0.000458	0.0355	CbGeAlD
Selegiline—CYP2A6—vagina—colon cancer	0.00045	0.0348	CbGeAlD
Selegiline—MAOA—renal system—colon cancer	0.000391	0.0302	CbGeAlD
Selegiline—CYP2A6—liver—colon cancer	0.000379	0.0294	CbGeAlD
Selegiline—MAOB—digestive system—colon cancer	0.000376	0.0291	CbGeAlD
Selegiline—ABCB1—blood vessel—colon cancer	0.00037	0.0286	CbGeAlD
Selegiline—CYP2C8—renal system—colon cancer	0.000349	0.027	CbGeAlD
Selegiline—MAOB—vagina—colon cancer	0.000332	0.0257	CbGeAlD
Selegiline—CYP2C19—digestive system—colon cancer	0.000328	0.0253	CbGeAlD
Selegiline—CYP1A2—renal system—colon cancer	0.000326	0.0252	CbGeAlD
Selegiline—MAOA—digestive system—colon cancer	0.000321	0.0248	CbGeAlD
Selegiline—CYP2B6—renal system—colon cancer	0.000313	0.0242	CbGeAlD
Selegiline—CYP2E1—renal system—colon cancer	0.000293	0.0227	CbGeAlD
Selegiline—CYP2C19—vagina—colon cancer	0.000289	0.0224	CbGeAlD
Selegiline—MAOA—vagina—colon cancer	0.000283	0.0219	CbGeAlD
Selegiline—MAOB—liver—colon cancer	0.00028	0.0217	CbGeAlD
Selegiline—CYP1A2—digestive system—colon cancer	0.000268	0.0207	CbGeAlD
Selegiline—CYP2B6—lymphoid tissue—colon cancer	0.00026	0.0201	CbGeAlD
Selegiline—CYP2B6—digestive system—colon cancer	0.000256	0.0198	CbGeAlD
Selegiline—CYP2C9—digestive system—colon cancer	0.000254	0.0196	CbGeAlD
Selegiline—CYP2C8—vagina—colon cancer	0.000252	0.0195	CbGeAlD
Selegiline—CYP2C19—liver—colon cancer	0.000244	0.0189	CbGeAlD
Selegiline—CYP2E1—lymphoid tissue—colon cancer	0.000244	0.0189	CbGeAlD
Selegiline—CYP2E1—digestive system—colon cancer	0.000241	0.0186	CbGeAlD
Selegiline—Conjunctivitis—Capecitabine—colon cancer	0.000239	0.0012	CcSEcCtD
Selegiline—MAOA—liver—colon cancer	0.000239	0.0185	CbGeAlD
Selegiline—Convulsion—Fluorouracil—colon cancer	0.000238	0.00119	CcSEcCtD
Selegiline—Osteoarthritis—Methotrexate—colon cancer	0.000238	0.00119	CcSEcCtD
Selegiline—Confusional state—Irinotecan—colon cancer	0.000236	0.00118	CcSEcCtD
Selegiline—Nervous system disorder—Vincristine—colon cancer	0.000236	0.00118	CcSEcCtD
Selegiline—CYP3A4—renal system—colon cancer	0.000236	0.0183	CbGeAlD
Selegiline—Thrombocytopenia—Vincristine—colon cancer	0.000236	0.00118	CcSEcCtD
Selegiline—Haematuria—Capecitabine—colon cancer	0.000235	0.00118	CcSEcCtD
Selegiline—Oedema—Irinotecan—colon cancer	0.000235	0.00118	CcSEcCtD
Selegiline—Chest pain—Fluorouracil—colon cancer	0.000234	0.00117	CcSEcCtD
Selegiline—Myalgia—Fluorouracil—colon cancer	0.000234	0.00117	CcSEcCtD
Selegiline—Infection—Irinotecan—colon cancer	0.000233	0.00117	CcSEcCtD
Selegiline—Hyperhidrosis—Vincristine—colon cancer	0.000233	0.00117	CcSEcCtD
Selegiline—Hepatobiliary disease—Capecitabine—colon cancer	0.000233	0.00117	CcSEcCtD
Selegiline—CYP2D6—renal system—colon cancer	0.000232	0.018	CbGeAlD
Selegiline—Epistaxis—Capecitabine—colon cancer	0.000232	0.00116	CcSEcCtD
Selegiline—Discomfort—Fluorouracil—colon cancer	0.000231	0.00116	CcSEcCtD
Selegiline—Shock—Irinotecan—colon cancer	0.000231	0.00116	CcSEcCtD
Selegiline—Nervous system disorder—Irinotecan—colon cancer	0.00023	0.00115	CcSEcCtD
Selegiline—Thrombocytopenia—Irinotecan—colon cancer	0.00023	0.00115	CcSEcCtD
Selegiline—Anorexia—Vincristine—colon cancer	0.00023	0.00115	CcSEcCtD
Selegiline—Irritability—Methotrexate—colon cancer	0.000227	0.00114	CcSEcCtD
Selegiline—Hyperhidrosis—Irinotecan—colon cancer	0.000227	0.00114	CcSEcCtD
Selegiline—CYP2B6—vagina—colon cancer	0.000226	0.0175	CbGeAlD
Selegiline—Confusional state—Fluorouracil—colon cancer	0.000226	0.00113	CcSEcCtD
Selegiline—Mood swings—Methotrexate—colon cancer	0.000225	0.00113	CcSEcCtD
Selegiline—Hypotension—Vincristine—colon cancer	0.000225	0.00113	CcSEcCtD
Selegiline—Bradycardia—Capecitabine—colon cancer	0.000225	0.00113	CcSEcCtD
Selegiline—Oedema—Fluorouracil—colon cancer	0.000225	0.00113	CcSEcCtD
Selegiline—Anorexia—Irinotecan—colon cancer	0.000224	0.00112	CcSEcCtD
Selegiline—Ataxia—Methotrexate—colon cancer	0.000224	0.00112	CcSEcCtD
Selegiline—Infection—Fluorouracil—colon cancer	0.000223	0.00112	CcSEcCtD
Selegiline—Rhinitis—Capecitabine—colon cancer	0.000221	0.00111	CcSEcCtD
Selegiline—Hepatitis—Capecitabine—colon cancer	0.000221	0.00111	CcSEcCtD
Selegiline—ABCB1—embryo—colon cancer	0.000221	0.0171	CbGeAlD
Selegiline—Nervous system disorder—Fluorouracil—colon cancer	0.00022	0.0011	CcSEcCtD
Selegiline—Thrombocytopenia—Fluorouracil—colon cancer	0.00022	0.0011	CcSEcCtD
Selegiline—Hypoaesthesia—Capecitabine—colon cancer	0.00022	0.0011	CcSEcCtD
Selegiline—Liver function test abnormal—Methotrexate—colon cancer	0.000219	0.0011	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Vincristine—colon cancer	0.000219	0.0011	CcSEcCtD
Selegiline—Pharyngitis—Capecitabine—colon cancer	0.000219	0.0011	CcSEcCtD
Selegiline—Tachycardia—Fluorouracil—colon cancer	0.000219	0.0011	CcSEcCtD
Selegiline—Hypotension—Irinotecan—colon cancer	0.000219	0.0011	CcSEcCtD
Selegiline—Urinary tract disorder—Capecitabine—colon cancer	0.000218	0.00109	CcSEcCtD
Selegiline—Insomnia—Vincristine—colon cancer	0.000218	0.00109	CcSEcCtD
Selegiline—Oedema peripheral—Capecitabine—colon cancer	0.000218	0.00109	CcSEcCtD
Selegiline—Urethral disorder—Capecitabine—colon cancer	0.000217	0.00109	CcSEcCtD
Selegiline—Paraesthesia—Vincristine—colon cancer	0.000216	0.00108	CcSEcCtD
Selegiline—MAOB—lymph node—colon cancer	0.000215	0.0166	CbGeAlD
Selegiline—Anorexia—Fluorouracil—colon cancer	0.000214	0.00107	CcSEcCtD
Selegiline—CYP2C8—liver—colon cancer	0.000213	0.0165	CbGeAlD
Selegiline—Visual impairment—Capecitabine—colon cancer	0.000213	0.00107	CcSEcCtD
Selegiline—Insomnia—Irinotecan—colon cancer	0.000212	0.00106	CcSEcCtD
Selegiline—Paraesthesia—Irinotecan—colon cancer	0.000211	0.00106	CcSEcCtD
Selegiline—Hypotension—Fluorouracil—colon cancer	0.00021	0.00105	CcSEcCtD
Selegiline—Decreased appetite—Vincristine—colon cancer	0.000209	0.00105	CcSEcCtD
Selegiline—Dyspnoea—Irinotecan—colon cancer	0.000209	0.00105	CcSEcCtD
Selegiline—Somnolence—Irinotecan—colon cancer	0.000208	0.00104	CcSEcCtD
Selegiline—Gastrointestinal disorder—Vincristine—colon cancer	0.000208	0.00104	CcSEcCtD
Selegiline—Fatigue—Vincristine—colon cancer	0.000208	0.00104	CcSEcCtD
Selegiline—Dyspepsia—Irinotecan—colon cancer	0.000206	0.00103	CcSEcCtD
Selegiline—Tinnitus—Capecitabine—colon cancer	0.000206	0.00103	CcSEcCtD
Selegiline—Pain—Vincristine—colon cancer	0.000206	0.00103	CcSEcCtD
Selegiline—Constipation—Vincristine—colon cancer	0.000206	0.00103	CcSEcCtD
Selegiline—Asthma—Methotrexate—colon cancer	0.000205	0.00103	CcSEcCtD
Selegiline—Flushing—Capecitabine—colon cancer	0.000205	0.00103	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000205	0.00103	CcSEcCtD
Selegiline—Decreased appetite—Irinotecan—colon cancer	0.000204	0.00102	CcSEcCtD
Selegiline—Eosinophilia—Methotrexate—colon cancer	0.000203	0.00102	CcSEcCtD
Selegiline—Insomnia—Fluorouracil—colon cancer	0.000203	0.00102	CcSEcCtD
Selegiline—Gastrointestinal disorder—Irinotecan—colon cancer	0.000202	0.00101	CcSEcCtD
Selegiline—Fatigue—Irinotecan—colon cancer	0.000202	0.00101	CcSEcCtD
Selegiline—Paraesthesia—Fluorouracil—colon cancer	0.000202	0.00101	CcSEcCtD
Selegiline—Pain—Irinotecan—colon cancer	0.000201	0.001	CcSEcCtD
Selegiline—Constipation—Irinotecan—colon cancer	0.000201	0.001	CcSEcCtD
Selegiline—Angiopathy—Capecitabine—colon cancer	0.0002	0.001	CcSEcCtD
Selegiline—Dyspnoea—Fluorouracil—colon cancer	0.0002	0.001	CcSEcCtD
Selegiline—Somnolence—Fluorouracil—colon cancer	0.0002	0.001	CcSEcCtD
Selegiline—CYP1A2—liver—colon cancer	0.000199	0.0154	CbGeAlD
Selegiline—Chills—Capecitabine—colon cancer	0.000198	0.000993	CcSEcCtD
Selegiline—Dyspepsia—Fluorouracil—colon cancer	0.000198	0.000991	CcSEcCtD
Selegiline—Arrhythmia—Capecitabine—colon cancer	0.000197	0.000989	CcSEcCtD
Selegiline—Gastrointestinal pain—Vincristine—colon cancer	0.000197	0.000987	CcSEcCtD
Selegiline—Decreased appetite—Fluorouracil—colon cancer	0.000195	0.000978	CcSEcCtD
Selegiline—Alopecia—Capecitabine—colon cancer	0.000195	0.000978	CcSEcCtD
Selegiline—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000194	0.000972	CcSEcCtD
Selegiline—CYP3A4—digestive system—colon cancer	0.000194	0.015	CbGeAlD
Selegiline—Mental disorder—Capecitabine—colon cancer	0.000194	0.00097	CcSEcCtD
Selegiline—Feeling abnormal—Irinotecan—colon cancer	0.000193	0.000968	CcSEcCtD
Selegiline—Malnutrition—Capecitabine—colon cancer	0.000192	0.000964	CcSEcCtD
Selegiline—Erythema—Capecitabine—colon cancer	0.000192	0.000964	CcSEcCtD
Selegiline—Dysuria—Methotrexate—colon cancer	0.000192	0.000963	CcSEcCtD
Selegiline—Pain—Fluorouracil—colon cancer	0.000192	0.000963	CcSEcCtD
Selegiline—Gastrointestinal pain—Irinotecan—colon cancer	0.000192	0.000961	CcSEcCtD
Selegiline—CYP2B6—liver—colon cancer	0.000191	0.0148	CbGeAlD
Selegiline—CYP2D6—digestive system—colon cancer	0.000191	0.0147	CbGeAlD
Selegiline—Abdominal pain—Vincristine—colon cancer	0.00019	0.000954	CcSEcCtD
Selegiline—Body temperature increased—Vincristine—colon cancer	0.00019	0.000954	CcSEcCtD
Selegiline—Flatulence—Capecitabine—colon cancer	0.000189	0.00095	CcSEcCtD
Selegiline—Erectile dysfunction—Methotrexate—colon cancer	0.000189	0.000948	CcSEcCtD
Selegiline—CYP2C9—liver—colon cancer	0.000189	0.0146	CbGeAlD
Selegiline—Dysgeusia—Capecitabine—colon cancer	0.000188	0.000944	CcSEcCtD
Selegiline—Photosensitivity reaction—Methotrexate—colon cancer	0.000188	0.00094	CcSEcCtD
Selegiline—Back pain—Capecitabine—colon cancer	0.000186	0.000932	CcSEcCtD
Selegiline—Body temperature increased—Irinotecan—colon cancer	0.000185	0.000929	CcSEcCtD
Selegiline—Abdominal pain—Irinotecan—colon cancer	0.000185	0.000929	CcSEcCtD
Selegiline—Feeling abnormal—Fluorouracil—colon cancer	0.000185	0.000928	CcSEcCtD
Selegiline—Muscle spasms—Capecitabine—colon cancer	0.000185	0.000927	CcSEcCtD
Selegiline—Pneumonia—Methotrexate—colon cancer	0.000184	0.000923	CcSEcCtD
Selegiline—Drowsiness—Methotrexate—colon cancer	0.000183	0.000918	CcSEcCtD
Selegiline—MAOA—lymph node—colon cancer	0.000183	0.0142	CbGeAlD
Selegiline—Depression—Methotrexate—colon cancer	0.000183	0.000915	CcSEcCtD
Selegiline—Vision blurred—Capecitabine—colon cancer	0.000181	0.000908	CcSEcCtD
Selegiline—ABCB1—epithelium—colon cancer	0.00018	0.0139	CbGeAlD
Selegiline—Tremor—Capecitabine—colon cancer	0.00018	0.000903	CcSEcCtD
Selegiline—CYP2E1—liver—colon cancer	0.000179	0.0139	CbGeAlD
Selegiline—Stomatitis—Methotrexate—colon cancer	0.000179	0.000895	CcSEcCtD
Selegiline—Ill-defined disorder—Capecitabine—colon cancer	0.000178	0.000894	CcSEcCtD
Selegiline—Urticaria—Fluorouracil—colon cancer	0.000178	0.000894	CcSEcCtD
Selegiline—Conjunctivitis—Methotrexate—colon cancer	0.000178	0.000892	CcSEcCtD
Selegiline—Anaemia—Capecitabine—colon cancer	0.000178	0.000891	CcSEcCtD
Selegiline—Body temperature increased—Fluorouracil—colon cancer	0.000178	0.00089	CcSEcCtD
Selegiline—Hypersensitivity—Vincristine—colon cancer	0.000177	0.000889	CcSEcCtD
Selegiline—Sweating—Methotrexate—colon cancer	0.000176	0.00088	CcSEcCtD
Selegiline—Haematuria—Methotrexate—colon cancer	0.000175	0.000875	CcSEcCtD
Selegiline—Malaise—Capecitabine—colon cancer	0.000173	0.000869	CcSEcCtD
Selegiline—Hepatobiliary disease—Methotrexate—colon cancer	0.000173	0.000868	CcSEcCtD
Selegiline—Epistaxis—Methotrexate—colon cancer	0.000173	0.000866	CcSEcCtD
Selegiline—Vertigo—Capecitabine—colon cancer	0.000173	0.000866	CcSEcCtD
Selegiline—Hypersensitivity—Irinotecan—colon cancer	0.000173	0.000866	CcSEcCtD
Selegiline—Asthenia—Vincristine—colon cancer	0.000173	0.000866	CcSEcCtD
Selegiline—Syncope—Capecitabine—colon cancer	0.000172	0.000864	CcSEcCtD
Selegiline—Leukopenia—Capecitabine—colon cancer	0.000172	0.000863	CcSEcCtD
Selegiline—Palpitations—Capecitabine—colon cancer	0.00017	0.000852	CcSEcCtD
Selegiline—Loss of consciousness—Capecitabine—colon cancer	0.000169	0.000847	CcSEcCtD
Selegiline—Asthenia—Irinotecan—colon cancer	0.000168	0.000843	CcSEcCtD
Selegiline—Cough—Capecitabine—colon cancer	0.000168	0.000841	CcSEcCtD
Selegiline—ABCB1—renal system—colon cancer	0.000167	0.0129	CbGeAlD
Selegiline—Hypertension—Capecitabine—colon cancer	0.000166	0.000832	CcSEcCtD
Selegiline—Hypersensitivity—Fluorouracil—colon cancer	0.000165	0.000829	CcSEcCtD
Selegiline—Diarrhoea—Vincristine—colon cancer	0.000165	0.000826	CcSEcCtD
Selegiline—Hepatitis—Methotrexate—colon cancer	0.000164	0.000824	CcSEcCtD
Selegiline—Arthralgia—Capecitabine—colon cancer	0.000164	0.00082	CcSEcCtD
Selegiline—Myalgia—Capecitabine—colon cancer	0.000164	0.00082	CcSEcCtD
Selegiline—Chest pain—Capecitabine—colon cancer	0.000164	0.00082	CcSEcCtD
Selegiline—Pharyngitis—Methotrexate—colon cancer	0.000163	0.000818	CcSEcCtD
Selegiline—Anxiety—Capecitabine—colon cancer	0.000163	0.000818	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000163	0.000815	CcSEcCtD
Selegiline—Urinary tract disorder—Methotrexate—colon cancer	0.000162	0.000814	CcSEcCtD
Selegiline—Discomfort—Capecitabine—colon cancer	0.000162	0.000811	CcSEcCtD
Selegiline—Urethral disorder—Methotrexate—colon cancer	0.000161	0.000808	CcSEcCtD
Selegiline—Diarrhoea—Irinotecan—colon cancer	0.00016	0.000804	CcSEcCtD
Selegiline—Dry mouth—Capecitabine—colon cancer	0.00016	0.000802	CcSEcCtD
Selegiline—Dizziness—Vincristine—colon cancer	0.000159	0.000798	CcSEcCtD
Selegiline—Pruritus—Fluorouracil—colon cancer	0.000159	0.000796	CcSEcCtD
Selegiline—Visual impairment—Methotrexate—colon cancer	0.000158	0.000794	CcSEcCtD
Selegiline—Confusional state—Capecitabine—colon cancer	0.000158	0.000793	CcSEcCtD
Selegiline—Oedema—Capecitabine—colon cancer	0.000157	0.000787	CcSEcCtD
Selegiline—Infection—Capecitabine—colon cancer	0.000156	0.000781	CcSEcCtD
Selegiline—Dizziness—Irinotecan—colon cancer	0.000155	0.000777	CcSEcCtD
Selegiline—Shock—Capecitabine—colon cancer	0.000154	0.000774	CcSEcCtD
Selegiline—Nervous system disorder—Capecitabine—colon cancer	0.000154	0.000771	CcSEcCtD
Selegiline—Diarrhoea—Fluorouracil—colon cancer	0.000154	0.00077	CcSEcCtD
Selegiline—Thrombocytopenia—Capecitabine—colon cancer	0.000154	0.00077	CcSEcCtD
Selegiline—Tinnitus—Methotrexate—colon cancer	0.000153	0.000768	CcSEcCtD
Selegiline—Tachycardia—Capecitabine—colon cancer	0.000153	0.000768	CcSEcCtD
Selegiline—Vomiting—Vincristine—colon cancer	0.000153	0.000767	CcSEcCtD
Selegiline—Skin disorder—Capecitabine—colon cancer	0.000152	0.000764	CcSEcCtD
Selegiline—Rash—Vincristine—colon cancer	0.000152	0.000761	CcSEcCtD
Selegiline—Hyperhidrosis—Capecitabine—colon cancer	0.000152	0.00076	CcSEcCtD
Selegiline—Dermatitis—Vincristine—colon cancer	0.000152	0.00076	CcSEcCtD
Selegiline—Headache—Vincristine—colon cancer	0.000151	0.000756	CcSEcCtD
Selegiline—Anorexia—Capecitabine—colon cancer	0.00015	0.00075	CcSEcCtD
Selegiline—Angiopathy—Methotrexate—colon cancer	0.000149	0.000748	CcSEcCtD
Selegiline—Vomiting—Irinotecan—colon cancer	0.000149	0.000747	CcSEcCtD
Selegiline—Dizziness—Fluorouracil—colon cancer	0.000149	0.000744	CcSEcCtD
Selegiline—Rash—Irinotecan—colon cancer	0.000148	0.000741	CcSEcCtD
Selegiline—Dermatitis—Irinotecan—colon cancer	0.000148	0.00074	CcSEcCtD
Selegiline—Chills—Methotrexate—colon cancer	0.000148	0.000739	CcSEcCtD
Selegiline—Headache—Irinotecan—colon cancer	0.000147	0.000736	CcSEcCtD
Selegiline—Hypotension—Capecitabine—colon cancer	0.000147	0.000735	CcSEcCtD
Selegiline—Alopecia—Methotrexate—colon cancer	0.000145	0.000728	CcSEcCtD
Selegiline—CYP3A4—liver—colon cancer	0.000144	0.0112	CbGeAlD
Selegiline—Mental disorder—Methotrexate—colon cancer	0.000144	0.000722	CcSEcCtD
Selegiline—Erythema—Methotrexate—colon cancer	0.000143	0.000717	CcSEcCtD
Selegiline—Malnutrition—Methotrexate—colon cancer	0.000143	0.000717	CcSEcCtD
Selegiline—Nausea—Vincristine—colon cancer	0.000143	0.000717	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000143	0.000717	CcSEcCtD
Selegiline—Vomiting—Fluorouracil—colon cancer	0.000143	0.000716	CcSEcCtD
Selegiline—CYP2D6—liver—colon cancer	0.000142	0.011	CbGeAlD
Selegiline—Insomnia—Capecitabine—colon cancer	0.000142	0.000711	CcSEcCtD
Selegiline—Rash—Fluorouracil—colon cancer	0.000142	0.00071	CcSEcCtD
Selegiline—Dermatitis—Fluorouracil—colon cancer	0.000141	0.000709	CcSEcCtD
Selegiline—Paraesthesia—Capecitabine—colon cancer	0.000141	0.000706	CcSEcCtD
Selegiline—Headache—Fluorouracil—colon cancer	0.000141	0.000705	CcSEcCtD
Selegiline—Dysgeusia—Methotrexate—colon cancer	0.00014	0.000703	CcSEcCtD
Selegiline—Dyspnoea—Capecitabine—colon cancer	0.00014	0.000701	CcSEcCtD
Selegiline—Nausea—Irinotecan—colon cancer	0.000139	0.000698	CcSEcCtD
Selegiline—ABCB1—lymphoid tissue—colon cancer	0.000139	0.0107	CbGeAlD
Selegiline—Back pain—Methotrexate—colon cancer	0.000138	0.000694	CcSEcCtD
Selegiline—Dyspepsia—Capecitabine—colon cancer	0.000138	0.000692	CcSEcCtD
Selegiline—ABCB1—digestive system—colon cancer	0.000137	0.0106	CbGeAlD
Selegiline—Decreased appetite—Capecitabine—colon cancer	0.000136	0.000684	CcSEcCtD
Selegiline—Gastrointestinal disorder—Capecitabine—colon cancer	0.000135	0.000679	CcSEcCtD
Selegiline—Fatigue—Capecitabine—colon cancer	0.000135	0.000678	CcSEcCtD
Selegiline—Vision blurred—Methotrexate—colon cancer	0.000135	0.000676	CcSEcCtD
Selegiline—Pain—Capecitabine—colon cancer	0.000134	0.000673	CcSEcCtD
Selegiline—Constipation—Capecitabine—colon cancer	0.000134	0.000673	CcSEcCtD
Selegiline—Nausea—Fluorouracil—colon cancer	0.000133	0.000669	CcSEcCtD
Selegiline—Ill-defined disorder—Methotrexate—colon cancer	0.000133	0.000666	CcSEcCtD
Selegiline—Anaemia—Methotrexate—colon cancer	0.000132	0.000663	CcSEcCtD
Selegiline—Feeling abnormal—Capecitabine—colon cancer	0.000129	0.000648	CcSEcCtD
Selegiline—Malaise—Methotrexate—colon cancer	0.000129	0.000647	CcSEcCtD
Selegiline—Vertigo—Methotrexate—colon cancer	0.000129	0.000645	CcSEcCtD
Selegiline—Gastrointestinal pain—Capecitabine—colon cancer	0.000128	0.000643	CcSEcCtD
Selegiline—Leukopenia—Methotrexate—colon cancer	0.000128	0.000642	CcSEcCtD
Selegiline—ABCB1—bone marrow—colon cancer	0.000126	0.00978	CbGeAlD
Selegiline—Cough—Methotrexate—colon cancer	0.000125	0.000626	CcSEcCtD
Selegiline—Urticaria—Capecitabine—colon cancer	0.000125	0.000625	CcSEcCtD
Selegiline—Body temperature increased—Capecitabine—colon cancer	0.000124	0.000622	CcSEcCtD
Selegiline—Abdominal pain—Capecitabine—colon cancer	0.000124	0.000622	CcSEcCtD
Selegiline—Convulsion—Methotrexate—colon cancer	0.000124	0.000622	CcSEcCtD
Selegiline—Chest pain—Methotrexate—colon cancer	0.000122	0.000611	CcSEcCtD
Selegiline—Arthralgia—Methotrexate—colon cancer	0.000122	0.000611	CcSEcCtD
Selegiline—Myalgia—Methotrexate—colon cancer	0.000122	0.000611	CcSEcCtD
Selegiline—ABCB1—vagina—colon cancer	0.000121	0.00937	CbGeAlD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000121	0.000607	CcSEcCtD
Selegiline—Discomfort—Methotrexate—colon cancer	0.00012	0.000603	CcSEcCtD
Selegiline—Confusional state—Methotrexate—colon cancer	0.000118	0.00059	CcSEcCtD
Selegiline—Infection—Methotrexate—colon cancer	0.000116	0.000582	CcSEcCtD
Selegiline—Hypersensitivity—Capecitabine—colon cancer	0.000116	0.000579	CcSEcCtD
Selegiline—Nervous system disorder—Methotrexate—colon cancer	0.000115	0.000574	CcSEcCtD
Selegiline—Thrombocytopenia—Methotrexate—colon cancer	0.000114	0.000573	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—colon cancer	0.000113	0.000569	CcSEcCtD
Selegiline—Hyperhidrosis—Methotrexate—colon cancer	0.000113	0.000566	CcSEcCtD
Selegiline—Asthenia—Capecitabine—colon cancer	0.000113	0.000564	CcSEcCtD
Selegiline—Anorexia—Methotrexate—colon cancer	0.000111	0.000558	CcSEcCtD
Selegiline—Pruritus—Capecitabine—colon cancer	0.000111	0.000556	CcSEcCtD
Selegiline—Hypotension—Methotrexate—colon cancer	0.000109	0.000547	CcSEcCtD
Selegiline—Diarrhoea—Capecitabine—colon cancer	0.000107	0.000538	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000106	0.000533	CcSEcCtD
Selegiline—Insomnia—Methotrexate—colon cancer	0.000106	0.00053	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—colon cancer	0.000105	0.000526	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—colon cancer	0.000104	0.000522	CcSEcCtD
Selegiline—Somnolence—Methotrexate—colon cancer	0.000104	0.000521	CcSEcCtD
Selegiline—Dizziness—Capecitabine—colon cancer	0.000104	0.00052	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—colon cancer	0.000103	0.000515	CcSEcCtD
Selegiline—ABCB1—liver—colon cancer	0.000102	0.0079	CbGeAlD
Selegiline—Decreased appetite—Methotrexate—colon cancer	0.000102	0.000509	CcSEcCtD
Selegiline—Gastrointestinal disorder—Methotrexate—colon cancer	0.000101	0.000506	CcSEcCtD
Selegiline—Fatigue—Methotrexate—colon cancer	0.000101	0.000505	CcSEcCtD
Selegiline—Pain—Methotrexate—colon cancer	9.99e-05	0.000501	CcSEcCtD
Selegiline—Vomiting—Capecitabine—colon cancer	9.98e-05	0.0005	CcSEcCtD
Selegiline—Rash—Capecitabine—colon cancer	9.9e-05	0.000496	CcSEcCtD
Selegiline—Dermatitis—Capecitabine—colon cancer	9.89e-05	0.000495	CcSEcCtD
Selegiline—Headache—Capecitabine—colon cancer	9.83e-05	0.000493	CcSEcCtD
Selegiline—Feeling abnormal—Methotrexate—colon cancer	9.63e-05	0.000483	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—colon cancer	9.55e-05	0.000479	CcSEcCtD
Selegiline—Nausea—Capecitabine—colon cancer	9.32e-05	0.000467	CcSEcCtD
Selegiline—Urticaria—Methotrexate—colon cancer	9.28e-05	0.000465	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—colon cancer	9.24e-05	0.000463	CcSEcCtD
Selegiline—Abdominal pain—Methotrexate—colon cancer	9.24e-05	0.000463	CcSEcCtD
Selegiline—Hypersensitivity—Methotrexate—colon cancer	8.61e-05	0.000431	CcSEcCtD
Selegiline—Asthenia—Methotrexate—colon cancer	8.38e-05	0.00042	CcSEcCtD
Selegiline—Pruritus—Methotrexate—colon cancer	8.27e-05	0.000414	CcSEcCtD
Selegiline—Diarrhoea—Methotrexate—colon cancer	7.99e-05	0.000401	CcSEcCtD
Selegiline—ABCB1—lymph node—colon cancer	7.83e-05	0.00606	CbGeAlD
Selegiline—Dizziness—Methotrexate—colon cancer	7.73e-05	0.000387	CcSEcCtD
Selegiline—Vomiting—Methotrexate—colon cancer	7.43e-05	0.000372	CcSEcCtD
Selegiline—Rash—Methotrexate—colon cancer	7.37e-05	0.000369	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—colon cancer	7.36e-05	0.000369	CcSEcCtD
Selegiline—Headache—Methotrexate—colon cancer	7.32e-05	0.000367	CcSEcCtD
Selegiline—Nausea—Methotrexate—colon cancer	6.94e-05	0.000348	CcSEcCtD
